Advertisement
Journal Home
Search for

Volume 42, Issue 15, Pages 2492-2498 (October 2006)


View previous. 11 of 35 View next.

Numerous high-risk epithelial lesions in familial breast cancer

N. HoogerbruggeabCorresponding Author Informationemail address, P. Bultc, J.J. Bonenkampd, M.J.L. Ligtenbergac, L.A. Kiemeneye, J.A. de Hulluf, C. Boetesg, M.F. Niermeijera, H.G. Brunnera

Received 27 January 2006; received in revised form 24 May 2006; accepted 24 May 2006.

Abstract 

Purpose

To assess the occurrence of high-risk epithelial lesions in women of breast cancer families with and without a BRCA mutation.

Patients and methods

Prospective study of women at very high risk of breast cancer undergoing prophylactic mastectomy (68 BRCA1 mutation carriers, 14 BRCA2 mutation carriers and 24 non-BRCA mutation carriers).

Results

The prevalence of high-risk lesions is equal in women with a BRCA1 or a BRCA2 mutation, but is higher in non-BRCA mutation carriers: all lesions 43% versus 71% (p=0.02), atypical lobular hyperplasia 26% versus 67% (p=0.001), atypical ductal hyperplasia 17% versus 42% (p=0.01), lobular carcinoma-in situ 15% versus 29% (p=0.10) and ductal carcinoma-in situ 9% versus 17% (p=0.25). The presence of high-risk lesions is related to absence of a BRCA mutation and to age over 40 years.

Conclusion

Women with an autosomal dominant family history for breast cancer, with and without a BRCA mutation are prone to develop high-risk epithelial lesions, especially over 40 years.

a Department of Human Genetics, From the Hereditary Cancer Clinic, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

b Department of Medical Oncology, From the Hereditary Cancer Clinic, Radboud University Nijmegen Medical Centre, The Netherlands

c Department of Pathology, From the Hereditary Cancer Clinic, Radboud University Nijmegen Medical Centre, The Netherlands

d Department of Surgery, From the Hereditary Cancer Clinic, Radboud University Nijmegen Medical Centre, The Netherlands

e Department of Epidemiology and Biostatistics, From the Hereditary Cancer Clinic, Radboud University Nijmegen Medical Centre, The Netherlands

f Department of Obstetrics and Gynecology, From the Hereditary Cancer Clinic, Radboud University Nijmegen Medical Centre, The Netherlands

g Department of Radiodiagnostics, From the Hereditary Cancer Clinic, Radboud University Nijmegen Medical Centre, The Netherlands

Corresponding Author InformationCorresponding author: Tel.: +31 24 3616577; fax: +31 24 3565026.

PII: S0959-8049(06)00529-6

doi:10.1016/j.ejca.2006.05.027


View previous. 11 of 35 View next.